Chico's FAS, Inc. : The USD 16.8 support area is tested
Entry price | Target | Stop-loss | Potential |
---|
$17.06 |
$0 |
$16.4 |
-100% |
---|
In the past few sessions, Chico's FAS shares have suffered from a sharp fall and is now coming back on a significant level support.
According to Surperformance rating, the company is an opportunity for a trading strategy. Indeed, it is a good compromise between its value and its visibility.
After several weeks of horizontal fluctuations within the mid-term range USD 16.8 / USD 19.64, the stock is coming back close to the lower limit of the range.
Moving averages are flat and technical indicators illustrate the oversold situation. The USD 16.8 area could cause a positive reaction for the coming trading sessions and allow a technical rebound towards the USD 17.87 mid-term resistance and then the pivot point at USD 18.68.
Therefore, the proximity of the USD 16.8 support is an opportunity to take a long position in Chico's FAS. The first goal is a return in the USD 17.87 resistance area, that is a potential of 4.7%. In fact, the security has to cross this area in order to re-establish a bullish trend in the short term. A stop loss order can be placed under the support currently tested.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.